Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model.
Solly, F
Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model. [electronic resource] - Cancer gene therapy Oct 2008 - 685-92 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1476-5500
10.1038/cgt.2008.36 doi
Angiostatins--metabolism
Angiotensin-Converting Enzyme Inhibitors--pharmacology
Animals
Blotting, Western
Captopril--pharmacology
Cell Line, Tumor
Combined Modality Therapy
Genetic Therapy--methods
Genetic Vectors--genetics
Glioma--drug therapy
Immunohistochemistry
Lentivirus--genetics
Male
Mice
Mice, Nude
Neovascularization, Pathologic--drug therapy
Platelet Endothelial Cell Adhesion Molecule-1--analysis
Rats
Tissue Plasminogen Activator--genetics
Tumor Burden--drug effects
Xenograft Model Antitumor Assays
Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model. [electronic resource] - Cancer gene therapy Oct 2008 - 685-92 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1476-5500
10.1038/cgt.2008.36 doi
Angiostatins--metabolism
Angiotensin-Converting Enzyme Inhibitors--pharmacology
Animals
Blotting, Western
Captopril--pharmacology
Cell Line, Tumor
Combined Modality Therapy
Genetic Therapy--methods
Genetic Vectors--genetics
Glioma--drug therapy
Immunohistochemistry
Lentivirus--genetics
Male
Mice
Mice, Nude
Neovascularization, Pathologic--drug therapy
Platelet Endothelial Cell Adhesion Molecule-1--analysis
Rats
Tissue Plasminogen Activator--genetics
Tumor Burden--drug effects
Xenograft Model Antitumor Assays